Send mail to Author

Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis (Article)

Please indicate your contact information and select, which author you want to contact.



 
  ______     ___     _____       ___     __   __     ___    
 /_   _//   / _ \\  |  __ \\    / _ \\   \ \\/ //   / _ \\  
 `-| |,-   | / \ || | |  \ ||  | / \ ||   \   //   / //\ \\ 
   | ||    | \_/ || | |__/ ||  | \_/ ||   / . \\  |  ___  ||
   |_||     \___//  |_____//    \___//   /_//\_\\ |_||  |_||
   `-`'     `---`    -----`     `---`    `-`  --` `-`   `-`
 


Back to frontdoor view

OPUS4 Logo